San Francisco, Tuesday 02 January 2018 10.00 PST
GAIA AG will present at the 2018 Biotech Showcase ™ to be held January 8 – 10 at the Hilton San Francisco Union Square. This is arguably one of the most important weeks in healthcare investor congresses.
GAIA is a global pioneer in digital therapy, successfully launching its first digital therapeutic in 2001. Our approach adopts the physician’s dialect, ensuring our software solutions are supported by randomized clinical trials and peer-reviewed medical publications showcased at leading conferences.
Dr Mario Weiss, GAIA’s Founder and CEO will present at the Biotech Showcase as follows:
Date: 8, January 2018
Time: 3:15pm (PST)
Room: B-Cyril Magnin III (4th Floor)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA
Our mission is to develop therapeutic software that offers physicians, therapists, payers and patients the same effect sizes, safety profiles, and convenience offered by foremost pharmaceutical solutions. GAIA’s multidisciplinary expert teams cover all competencies required to develop, launch and maintain premium products for major markets. GAIA’s current R&D pipeline covers a range of phase II and phase III next-generation digital therapy solution, for conditions such as multiple sclerosis (elevida®), cancer (optimune®), diabetes compliance management (covivio®), among others.
Biotech Showcase™ is an investor and networking conference. It is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives during one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
“We are delighted that GAIA AG will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation…” said Sara Demy-Colton, CEO of Demy-Colton, organizers of the Biotech Showcase.